NeoGenomics, Inc. (NASDAQ:NEO) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
NeoGenomics, Inc.

PRESS RELEASE

published on 12/28/2023 at 14:10, 10 months 23 days ago

NeoGenomics to Appeal Ruling
NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
PRESS RELEASE

published on 12/05/2023 at 14:00, 11 months 15 days ago

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial

NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
PRESS RELEASE

published on 11/14/2023 at 13:00, 1 year ago

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
PRESS RELEASE

published on 11/06/2023 at 22:05, 1 year ago

NeoGenomics Reports Third Quarter 2023 Results
PRESS RELEASE

published on 10/24/2023 at 13:00, 1 year ago

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
PRESS RELEASE

published on 10/17/2023 at 15:20, 1 year 1 month ago

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

Accesswire

Published on 11/21/2024 at 10:03, 47 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 50 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 50 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 15 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 25 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 20 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 45 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 48 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 50 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 50 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 30 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 5 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 5 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE